Updated May 2021
Chapters are reviewed on an ongoing basis. The review date is indicated within each chapter.
This manual describes standard practice for public health services to follow for the prevention and control of notifiable diseases (ie, the specific communicable diseases that are required to be notified by medical practitioners and laboratories under the Health Act 1956). It is intended chiefly for those at the frontline of public health action – medical officers of health, health protection officers and staff at public health units.
Most of the information is contained within disease-specific chapters (see below). These include case definitions and laboratory tests required for case confirmation, along with references and links to more information. Some important general considerations are outlined in their own chapters and in the appendices.
The disease-specific chapters are intended to be reviewed and updated separately in accordance with new evidence and best practice. See Updates to the Communicable Disease Control Manual for a list of chapter updates.
Use this manual in conjunction with other best practice guidelines, such as the Immunisation Handbook, and with effective existing local-level practices. We encourage those with effective evidence-based local practices to bring them forward for broader consideration and possible incorporation in this manual.
While the protocols set out in the manual reflect normal expectations, they may require adaptation in particular circumstances (eg, in a significant outbreak or epidemic). This should be determined based on the professional judgement of the local medical officer of health.
Please send feedback to [email protected].
- Foreword and acknowledgements
- General consideration for the control of communicable diseases in New Zealand
- Acquired immunodeficiency syndrome (AIDS)
- Acute gastroenteritis
- Arboviral diseases
- Creutzfeldt-Jakob disease and other spongiform encephalopathies
- Cronobacter species invasive disease
- Gonorrhoea (case definition only)
- Haemophilus influenzae type b invasive disease (Hib)
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis (viral) – not otherwise specified
- Highly pathogenic avian influenza
- Human immunodeficiency virus (HIV)
- Hydatid disease
- Invasive pneumococcal disease
- Meningoencephalitis – primary amoebic
- Middle East respiratory syndrome
- Neisseria meningitidis invasive disease
- Non-seasonal influenza
- Q fever
- Rabies and other lyssaviruses
- Rheumatic fever
- Rickettsial diseases
- Rubella: congenital
- Severe acute respiratory syndrome (SARS)
- Syphilis (case definition only)
- Typhoid and paratyphoid fever
- Verocytotoxin- or Shiga toxin- producing Escherichia coli (VTEC/STEC)
- Viral haemorrhagic fevers
- Yellow fever
- Appendix 1: Disinfection
- Appendix 2: Enteric disease
- Appendix 3: Patient information
- Appendix 4: Direct laboratory notification of communicable diseases flowcharts